BBIO

BBIO Operating Expenses

$1.21BTTM · USD

Period ending:

BBIO FY Operating ExpensesUSD
BBIO FY Operating Expenses2017-12-31: $43.86M2018-12-31: $183.66M2019-12-31: $304.30M2020-12-31: $482.73M2021-12-31: $643.23M2022-12-31: $586.42M2023-12-31: $614.23M2024-12-31: $811.00M2025-12-31: $1.04B$1.04B$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BBIO operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Bridgebio Pharma Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
1,042,892,000
810,997,000
614,227,000
586,416,000
643,234,000
482,731,000
304,300,000
183,660,000
43,858,000

Compare operating expenses

All BBIO financial metrics · BBIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.